Related references
Note: Only part of the references are listed.Path mediation analysis reveals GBA impacts Lewy body disease status by increasing α-synuclein levels
Anna Lisa Gundner et al.
NEUROBIOLOGY OF DISEASE (2019)
Updates on immunity and inflammation in Parkinson disease pathology
Neeraj Joshi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2018)
Phospholipase D1 downregulation by α-synuclein: Implications for neurodegeneration in Parkinson's disease
Melisa A. Conde et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function
Myung Jong Kim et al.
HUMAN MOLECULAR GENETICS (2018)
Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated -synuclein
Emma I. O'Leary et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Augmented frontal cortex diacylglycerol levels in Parkinson's disease and Lewy Body Disease
Paul L. Wood et al.
PLOS ONE (2018)
Cardiolipin exposure on the outer mitochondrial membrane modulates alpha-synuclein
Tammy Ryan et al.
NATURE COMMUNICATIONS (2018)
Lipid metabolism alterations in the neuronal response to A53T α-synuclein and Fe-induced injury
Sofia Sanchez Campos et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2018)
Higher Serum Cholesterol and Decreased Parkinson's Disease Risk: A Statin-Free Cohort Study
Violetta Rozani et al.
MOVEMENT DISORDERS (2018)
Lipid-dependent deposition of alpha-synuclein and Tau on neuronal Secretogranin II-positive vesicular membranes with age
Oeystein R. Brekk et al.
SCIENTIFIC REPORTS (2018)
Mitochondrial lipids in neurodegeneration
Andreas Aufschnaiter et al.
CELL AND TISSUE RESEARCH (2017)
Modelling idiopathic Parkinson disease as a complex illness can inform incidence rate in healthy adults: thePREDIGT score
Michael G. Schlossmacher et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
Lipid profiling of parkin-mutant human skin fibroblasts
Simona Lobasso et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease
Yumiko V. Taguchi et al.
JOURNAL OF NEUROSCIENCE (2017)
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
Nahid Tayebi et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Cerebrospinal Fluid β-Glucocerebrosidase Activity Is Reduced in Parkinson's Disease Patients
Lucilla Parnetti et al.
MOVEMENT DISORDERS (2017)
SMPD1 variants in Chinese Han patients with sporadic Parkinson's disease
Cheng-yuan Mao et al.
PARKINSONISM & RELATED DISORDERS (2017)
Serum lipid alterations in GBA-associated Parkinson's disease
Leonor Correia Guedes et al.
PARKINSONISM & RELATED DISORDERS (2017)
Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Genetic Determinants of Parkinson's Disease: Can They Help to Stratify the Patients Based on the Underlying Molecular Defect?
Sara Redensek et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
The Role of Lipids Interacting with α-Synuclein in the Pathogenesis of Parkinson's Disease
Celine Galvagnion
JOURNAL OF PARKINSONS DISEASE (2017)
Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis
Robin B. Chan et al.
PLOS ONE (2017)
Parkinson's Disease: A Traffic Jam?
Michael J. Clague et al.
CURRENT BIOLOGY (2016)
Monomeric Alpha-Synuclein Exerts a Physiological Role on Brain ATP Synthase
Marthe H. R. Ludtmann et al.
JOURNAL OF NEUROSCIENCE (2016)
Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein
Celine Galvagnion et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Interaction of alpha-synuclein with biomembranes in Parkinson's disease -role of cardiolipin
Stephanie Ghio et al.
PROGRESS IN LIPID RESEARCH (2016)
Versatile Structures of α-Synuclein
Chuchu Wang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Statin Use and the Risk of Parkinson's Disease: An Updated Meta-Analysis
Shuang Bai et al.
PLOS ONE (2016)
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson disease
Ziv Gan-Or et al.
AUTOPHAGY (2015)
Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction
Kerri J. Kinghorn et al.
BRAIN (2015)
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations
Roy N. Alcalay et al.
BRAIN (2015)
Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant α-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease
Mari Suzuki et al.
HUMAN MOLECULAR GENETICS (2015)
Major Alterations of Phosphatidylcholine and Lysophosphotidylcholine Lipids in the Substantia Nigra Using an Early Stage Model of Parkinson's Disease
Kyle Farmer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
No evidence for substrate accumulation in Parkinson brains with GBA mutations
Matthew E. Gegg et al.
MOVEMENT DISORDERS (2015)
The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews
E. Dagan et al.
PARKINSONISM & RELATED DISORDERS (2015)
Parkinson's disease: From human genetics to clinical trials
Marcel P. van der Brug et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
Brent J. Ryan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Progress in unraveling the genetic etiology of Parkinson disease in a genomic era
Aline Verstraeten et al.
TRENDS IN GENETICS (2015)
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Lorraine V. Kalia et al.
JAMA NEUROLOGY (2015)
Potentiation of neurotoxicity in double-mutant mice with Pink1 ablation and A53T-SNCA overexpression
Suzana Gispert et al.
HUMAN MOLECULAR GENETICS (2015)
Acceleration of α-Synuclein Aggregation by Exosomes
Marie Grey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Disturbed mitochondrial dynamics and neurodegenerative disorders
Florence Burte et al.
NATURE REVIEWS NEUROLOGY (2015)
Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation
Eun-Jin Bae et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Glucocerebrosidase deficits in sporadic Parkinson disease
Karen E. Murphy et al.
AUTOPHAGY (2014)
SREBF1 links lipogenesis to mitophagy and sporadic Parkinson disease
Rachael M. Ivatt et al.
AUTOPHAGY (2014)
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson's disease
Karen E. Murphy et al.
BRAIN (2014)
Phospholipase D1 regulates autophagic flux and clearance of α-synuclein aggregates
E-J Bae et al.
CELL DEATH AND DIFFERENTIATION (2014)
Alpha-Synuclein Binds to the Inner Membrane of Mitochondria in an α-Helical Conformation
Marta Robotta et al.
CHEMBIOCHEM (2014)
N-terminal Acetylation Stabilizes N-terminal Helicity in Lipid- and Micelle-bound α-Synuclein and Increases Its Affinity for Physiological Membranes
Igor Dikiy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
alpha-Synuclein Is Localized to Mitochondria-Associated ER Membranes
Cristina Guardia-Laguarta et al.
JOURNAL OF NEUROSCIENCE (2014)
Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson's disease
Sarah K. Abbott et al.
MOVEMENT DISORDERS (2014)
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease
Mike A. Nalls et al.
NATURE GENETICS (2014)
Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy
Rachael M. Ivatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Phosphatidylethanolamine deficiency disrupts α-synuclein homeostasis in yeast and worm models of Parkinson disease
Shaoxiao Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis
David C. Schoendorf et al.
NATURE COMMUNICATIONS (2014)
Direct observation of the three regions in α-synuclein that determine its membrane-bound behaviour
Giuliana Fusco et al.
NATURE COMMUNICATIONS (2014)
Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
Douglas G. Walker et al.
EXPERIMENTAL NEUROLOGY (2013)
Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies
Claudia Manzoni et al.
FASEB JOURNAL (2013)
Binding and Aggregation Mechanism of Amyloid β-Peptides onto the GM1 Ganglioside-Containing Lipid Membrane
Tyuji Hoshino et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients
Jay S. Schneider et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Parkin disease and the Lewy body conundrum
Karen M. Doherty et al.
MOVEMENT DISORDERS (2013)
The many faces of alpha-synuclein: from structure and toxicity to therapeutic target
Hilal A. Lashuel et al.
NATURE REVIEWS NEUROSCIENCE (2013)
Platelet-activating factor receptor knockout mice are protected from MPTP-induced dopaminergic degeneration
Beom Keun Kim et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease
Ziv Gan-Or et al.
NEUROLOGY (2013)
Blood-based biomarkers for Parkinson's disease
Lama M. Chahine et al.
PARKINSONISM & RELATED DISORDERS (2013)
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study
Michelle M. Mielke et al.
PLOS ONE (2013)
α-Synuclein Oligomers Induced by Docosahexaenoic Acid Affect Membrane Integrity
Chiara Fecchio et al.
PLOS ONE (2013)
Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
Grit Taschenberger et al.
ACTA NEUROPATHOLOGICA (2012)
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Matthew E. Gegg et al.
ANNALS OF NEUROLOGY (2012)
Impact of N-Terminal Acetylation of α-Synuclein on Its Random Coil and Lipid Binding Properties
Alexander S. Maltsev et al.
BIOCHEMISTRY (2012)
Interaction of α-synuclein with vesicles that mimic mitochondrial membranes
Imola G. Zigoneanu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2012)
Biochemical Increase in Phosphorylated Alpha-Synuclein Precedes Histopathology of Lewy-Type Synucleinopathies
Lih-Fen Lue et al.
BRAIN PATHOLOGY (2012)
Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation
Igor F. Tsigelny et al.
FEBS JOURNAL (2012)
Characterization of Semisynthetic and Naturally Nα-Acetylated α-Synuclein in Vitro and in Intact Cells IMPLICATIONS FOR AGGREGATION AND CELLULAR PROPERTIES OF α-SYNUCLEIN
Bruno Fauvet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
Gusheng Wu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
The link between the GBA gene and parkinsonism
Ellen Sidransky et al.
LANCET NEUROLOGY (2012)
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology
Debby Tsuang et al.
NEUROLOGY (2012)
Chain length-specific properties of ceramides
Sabine Groesch et al.
PROGRESS IN LIPID RESEARCH (2012)
Parkinson Disease: Research Update and Clinical Management
Thomas Fritsch et al.
SOUTHERN MEDICAL JOURNAL (2012)
Genetics of Parkinson's Disease
Christine Klein et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Acid β-Glucosidase Mutants Linked to Gaucher Disease, Parkinson Disease, and Lewy Body Dementia Alter α-Synuclein Processing
Valerie Cullen et al.
ANNALS OF NEUROLOGY (2011)
The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry
Barry Rosenbloom et al.
BLOOD CELLS MOLECULES AND DISEASES (2011)
Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
Joseph R. Mazzulli et al.
CELL (2011)
Dissection of the genetics of Parkinson's disease identifies an additional association 5′ of SNCA and multiple associated haplotypes at 17q21
Chris C. A. Spencer et al.
HUMAN MOLECULAR GENETICS (2011)
Structural and Morphological Characterization of Aggregated Species of α-Synuclein Induced by Docosahexaenoic Acid
Giorgia De Franceschi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein
Ken Nakamura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Membrane Lipid Modification by Docosahexaenoic Acid (DHA) Promotes the Formation of α-Synuclein Inclusion Bodies Immunopositive for SUMO-1 in Oligodendroglial Cells After Oxidative Stress
Michael Riedel et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2011)
The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1-and DJ-1-deficiency in dopaminergic neuronal cells
Jung Hee Shim et al.
MITOCHONDRION (2011)
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models
Y. H. Xu et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Severe Alterations in Lipid Composition of Frontal Cortex Lipid Rafts from Parkinson's Disease and Incidental Parkinson's Disease
Noemi Fabelo et al.
MOLECULAR MEDICINE (2011)
GBA-associated PD presents with nonmotor characteristics
K. Brockmann et al.
NEUROLOGY (2011)
Multi-organ autonomic dysfunction in Parkinson disease
Samay Jain
PARKINSONISM & RELATED DISORDERS (2011)
Neuroinflammation in Parkinson's disease
Etienne C. Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2011)
Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex
Danni Cheng et al.
PLOS ONE (2011)
Serum Cholesterol and the Progression of Parkinson's Disease: Results from DATATOP
Xuemei Huang et al.
PLOS ONE (2011)
CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
S. Pablo Sardi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Biomarkers of Parkinson's disease and Dementia with Lewy bodies
Claire Henchcliffe et al.
PROGRESS IN NEUROBIOLOGY (2011)
Exploring the link between glucocerebrosidase mutations and parkinsonism
Wendy Westbroek et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease
Chuong B. Do et al.
PLOS GENETICS (2011)
Membrane Interaction of alpha-Synuclein in Different Aggregation States
Marie Grey et al.
JOURNAL OF PARKINSONS DISEASE (2011)
Lipid-Mediated Oxidative Stress and Inflammation in the Pathogenesis of Parkinson's Disease
Tahira Farooqui et al.
PARKINSONS DISEASE (2011)
Inhibition of mitochondrial fusion by α-synuclein is rescued by PINK1, Parkin and DJ-1
Frits Kamp et al.
EMBO JOURNAL (2010)
Oxidative damage in Parkinson disease: Measurement using accurate biomarkers
Raymond C. S. Seet et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Pathological aspects of lipid peroxidation
Anne Negre-Salvayre et al.
FREE RADICAL RESEARCH (2010)
Altered Ion Channel Formation by the Parkinson's-Disease-Linked E46K Mutant of α-Synuclein Is Corrected by GM3 but Not by GM1 Gangliosides
Eric Di Pasquale et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
GM1 ganglioside in Parkinson's disease: Results of a five year open study
Jay S. Schneider et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Case-control study of risk of Parkinson's disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
Yoshihiro Miyake et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
Oxidation Changes Physical Properties of Phospholipid Bilayers: Fluorescence Spectroscopy and Molecular Simulations
Lenka Beranova et al.
LANGMUIR (2010)
α-Synuclein Expression in Rat Substantia Nigra Suppresses Phospholipase D2 Toxicity and Nigral Neurodegeneration
Oleg S. Gorbatyuk et al.
MOLECULAR THERAPY (2010)
Phenotypic spectrum of patients with PLA2G6 mutation and PARK14-linked parkinsonism
H. Yoshino et al.
NEUROLOGY (2010)
The Role of the Ceramide Acyl Chain Length in Neurodegeneration: Involvement of Ceramide Synthases
Oshrit Ben-David et al.
NEUROMOLECULAR MEDICINE (2010)
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
Venu M. Nemani et al.
NEURON (2010)
Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor
Lorraine N. Clark et al.
PARKINSONISM & RELATED DISORDERS (2010)
Alpha-synuclein, lipids and Parkinson's disease
Violeta Ruiperez et al.
PROGRESS IN LIPID RESEARCH (2010)
Protective Role of Endogenous Gangliosides for Lysosomal Pathology in a Cellular Model of Synucleinopathies
Jianshe Wei et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Characterization of PLA2G6 as a Locus for Dystonia-Parkinsonism
Coro Paisan-Ruiz et al.
ANNALS OF NEUROLOGY (2009)
Evidence That α-Synuclein Does Not Inhibit Phospholipase D
Irit Rappley et al.
BIOCHEMISTRY (2009)
Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations
Z. Gan-Or et al.
BRAIN (2009)
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
Juliane Neumann et al.
BRAIN (2009)
R632W mutation in PLA2G6 segregates with dystonia-parkinsonism in a consanguineous Iranian family
F. Sina et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Genomewide association study for susceptibility genes contributing to familial Parkinson disease
Nathan Pankratz et al.
HUMAN GENETICS (2009)
The challenge of lipid rafts
Linda J. Pike
JOURNAL OF LIPID RESEARCH (2009)
Molecular Insights into the Interaction between α-Synuclein and Docosahexaenoic Acid
Giorgia De Franceschi et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
Multiple Tight Phospholipid-Binding Modes of α-Synuclein Revealed by Solution NMR Spectroscopy
Christina R. Bodner et al.
JOURNAL OF MOLECULAR BIOLOGY (2009)
The role of α-synuclein in brain lipid metabolism: a downstream impact on brain inflammatory response
Mikhail Y. Golovko et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
VDAC and ERα interaction in caveolae from human cortex is altered in Alzheimer's disease
Cristina M. Ramirez et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Early involvement of the cerebral cortex in Parkinson's disease: Convergence of multiple metabolic defects
Isidre Ferrer
PROGRESS IN NEUROBIOLOGY (2009)
Animal models of Parkinson's disease progression
Gloria E. Meredith et al.
ACTA NEUROPATHOLOGICA (2008)
Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease
K. Markopoulou et al.
ACTA NEUROPATHOLOGICA (2008)
Diacylglycerol kinases: at the hub of cell signalling
Isabel Merida et al.
BIOCHEMICAL JOURNAL (2008)
Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
Sabine Wislet-Gendebien et al.
BMC NEUROSCIENCE (2008)
Mitochondrial translocation of α-synuclein is promoted by intracellular acidification
Nelson B. Cole et al.
EXPERIMENTAL CELL RESEARCH (2008)
Emerging pathways in genetic Parkinson's disease: Potential role of ceramide metabolism in Lewy body disease
Jose Bras et al.
FEBS JOURNAL (2008)
Functional mitochondria are required for α-synuclein toxicity in aging yeast
Sabrina Buettner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties
Timothy J. Cunningham et al.
JOURNAL OF INFLAMMATION-LONDON (2008)
Optical Reporters for the Conformation of α-Synuclein Reveal a Specific Interaction with Mitochondria
Ken Nakamura et al.
JOURNAL OF NEUROSCIENCE (2008)
Docosahexaenoic Acid and the Aging Brain
Walter J. Lukiw et al.
JOURNAL OF NUTRITION (2008)
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Anthony H. V. Schapira
LANCET NEUROLOGY (2008)
Low LDL cholesterol and increased risk of Parkinson's disease: Prospective results from Honolulu-Asia Aging Study
Xuemei Huang et al.
MOVEMENT DISORDERS (2008)
Statin use and the risk of Parkinson disease
Angelika D. Wahner et al.
NEUROLOGY (2008)
Total cholesterol and the risk of Parkinson disease
G. Hu et al.
NEUROLOGY (2008)
Regulation of brain polyunsaturated fatty acid uptake and turnover
Chuck T. Chen et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2008)
Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: analysis of human brain tissue
Kimiko Hamano et al.
ACTA NEUROPATHOLOGICA (2008)
Polyunsaturated fatty acids induce α-synuclein-related pathogenic changes in neuronal cells
Karen Assayag et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Neuronal and glial accumulation of α- and β-synucleins in human lipidoses
Kyoko Suzuki et al.
ACTA NEUROPATHOLOGICA (2007)
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
Kelly Claire Simon et al.
NEUROLOGY (2007)
Role of α-synuclein in synaptic glutamate release
Irina Gureviciene et al.
NEUROBIOLOGY OF DISEASE (2007)
The group VIA calcium-independent phospholipase A2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral Sphingomyelinase
Xiaoyong Lei et al.
BIOCHEMISTRY (2007)
Brain neutral lipids mass is increased in α-synuclein gene-ablated mice
Gwendolyn Barcelo-Coblijn et al.
JOURNAL OF NEUROCHEMISTRY (2007)
α-Synuclein gene ablation increases docosahexaenoic acid incorporation and turnover in brain phospholipids
Mikhail Y. Golovko et al.
JOURNAL OF NEUROCHEMISTRY (2007)
GM1 specifically interacts with α-synuclein and inhibits fibrillation
Zak Martinez et al.
BIOCHEMISTRY (2007)
Lipid raft microdomains and neurotransmitter signalling
John A. Allen et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
E. R. Dorsey et al.
NEUROLOGY (2007)
Voltage-dependent anion channel (VDAC) participates in amyloid beta-induced toxicity and interacts with plasma membrane estrogen receptor alpha in septal and hippocampal neurons
Raquel Marin et al.
MOLECULAR MEMBRANE BIOLOGY (2007)
α-synuclein adopts an α-helical conformation in the presence of polyunsaturated fatty acids to hinder micelle formation
Kerensa Broersen et al.
BIOCHEMISTRY (2006)
Serum cholesterol levels and the risk of Parkinson's disease
Lonneke M. L. de lau et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
α-synuclein expression modulates microglial activation phenotype
Susan A. Austin et al.
JOURNAL OF NEUROSCIENCE (2006)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The aggregation and fibrillation of α-synuclein
Anthony L. Fink
ACCOUNTS OF CHEMICAL RESEARCH (2006)
Functional characterisation of ganglioside-induced differentiation-associated protein 1 as a glutathione transferase
Alison J. Shield et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Acyl-CoA synthetase activity links wild-type but not mutant α-synuclein to brain arachidonate metabolism
Mikhail Y. Golovko et al.
BIOCHEMISTRY (2006)
Reduced risk factors for vascular disorders in Parkinson disease patients - A case-control study
G Scigliano et al.
STROKE (2006)
Upregulation of α-synuclein in neurons and glia in inflammatory demyelinating disease
D Papadopoulos et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2006)
Expanding insights of mitochondrial dysfunction in Parkinson's disease
PM Abou-Sleiman et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Oxidative stress and neurodegeneration: where are we now?
Barry Halliwell
JOURNAL OF NEUROCHEMISTRY (2006)
Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking α-synuclein
CE Ellis et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Fatty acid incorporation is decreased in astrocytes cultured from α-synuclein gene-ablated mice
PI Castagnet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
α-Synuclein gene deletion decreases brain palmitate uptake and alters the palmitate metabolism in the absence of α-synuclein palmitate binding
MY Golovko et al.
BIOCHEMISTRY (2005)
Fluorescence studies suggest a role for α-synuclein in the phosphatidylinositol lipid signaling pathway
V Narayanan et al.
BIOCHEMISTRY (2005)
Mitochondrial dysfunction and oxidative damage in parkin-deficient mice
JJ Palacino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Structural determinants of PLD2 inhibition by α-synuclein
JE Payton et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Abnormal α-synuclein interactions with rab proteins in α-synuclein A30P transgenic mice
E Dalfó et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
The induction of amyloid precursor protein and α-synuclein in rat hippocarnpal astrocytes by diethyldithiocarbamate and copper with or without glutathione
SY Cheng et al.
TOXICOLOGY LETTERS (2004)
Cholesterol metabolism in the central nervous system during early development and in the mature animal
JM Dietschy et al.
JOURNAL OF LIPID RESEARCH (2004)
Lipid rafts mediate the synaptic localization of α-synuclein
DL Fortin et al.
JOURNAL OF NEUROSCIENCE (2004)
A seed for Alzheimer amyloid in the brain
H Hayashi et al.
JOURNAL OF NEUROSCIENCE (2004)
α-Synuclein regulation of the dopaminergic transporter:: a possible role in the pathogenesis of Parkinson's disease
A Sidhu et al.
FEBS LETTERS (2004)
Inflammation and neurodegeneration in Parkinson's disease
PL McGeer et al.
PARKINSONISM & RELATED DISORDERS (2004)
Altered fatty acid composition of dopaminergic neurons expressing α-synuclein and human brains with α-synucleinopathies
R Sharon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or α-synuclein
S Willingham et al.
SCIENCE (2003)
The association of α-synuclein with membranes affects bilayer structure, stability, and fibril formation
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lipid binding inhibits α-synuclein fibril formation
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Attenuation of dopamine transporter activity by α-synuclein
C Wersinger et al.
NEUROSCIENCE LETTERS (2003)
Lipid rafts: bringing order to chaos
LJ Pike
JOURNAL OF LIPID RESEARCH (2003)
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
JC Greene et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Role of cholesterol in synapse formation and function
FW Pfrieger
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
The formation of highly soluble oligomers of α-synuclein is regulated by fatty acids and enhanced in Parkinson's disease
R Sharon et al.
NEURON (2003)
Oxidative stress in Parkinson's disease
P Jenner
ANNALS OF NEUROLOGY (2003)
Demonstration of α-synuclein immunoreactivity in neuronal and glial cytoplasm in normal human brain tissue using proteinase K and formic acid pretreatment
F Mori et al.
EXPERIMENTAL NEUROLOGY (2002)
A role for α-synuclein in the regulation of dopamine biosynthesis
RG Perez et al.
JOURNAL OF NEUROSCIENCE (2002)
Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein
NB Cole et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins
RJ Perrin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
α-synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins
R Sharon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Glia-derived signals induce synapse formation in neurones of the rat central nervous system
K Nägler et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Conformational properties of α-synuclein in its free and lipid-associated states
D Eliezer et al.
JOURNAL OF MOLECULAR BIOLOGY (2001)
Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
FJS Lee et al.
FASEB JOURNAL (2001)
Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents
M Tariq et al.
BRAIN RESEARCH BULLETIN (2001)
α-synuclein membrane interactions and lipid specificity
EJ Jo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The A53T α-synuclein mutation increases iron-dependent aggregation and toxicity
N Ostrerova-Golts et al.
JOURNAL OF NEUROSCIENCE (2000)
Structure and function of sphingolipid- and cholesterol-rich membrane rafts
DA Brown et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Synucleins are developmentally expressed, and α-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons
DD Murphy et al.
JOURNAL OF NEUROSCIENCE (2000)
Possible involvement of cytosolic phospholipase A2 in cell death induced by 1-methyl-4-phenylpyridinium ion, a dopaminergic neurotoxin, in GH3 cells
N Yoshinaga et al.
BRAIN RESEARCH (2000)
Ceramide in the eukaryotic stress response
YA Hannun et al.
TRENDS IN CELL BIOLOGY (2000)
Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system
A Abeliovich et al.
NEURON (2000)
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain
PJ Kahle et al.
JOURNAL OF NEUROSCIENCE (2000)
Share Paper
